Vimarsana
Biggest News Aggregation in the World

Page 3 - Consensus Decision Pathway News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Consensus Decision Pathway. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Consensus Decision Pathway Today - Breaking & Trending Today

Novartis Pharma AG: Novartis Entresto receives positive CHMP opinion for pediatric heart failure - Vimarsana News

Novartis Pharma AG: Novartis Entresto receives positive CHMP opinion for pediatric heart failure

If subsequently approved, Entresto will be the first and only approved therapy for the treatment of symptomatic chronic heart failure patients aged 1 to Pediatric heart failure is an important cause

Don't Just Prescribe a Statin—Measure and Control LDL, Say NLA, ASPC - Vimarsana News

Don't Just Prescribe a Statin—Measure and Control LDL, Say NLA, ASPC

A new statement argues for the return of a performance metric that sees physicians track the efficacy of their LDL-C treatments.

Source: tctmd.com
ACC Issues Expert Consensus Decision Pathway on Cardiac Amyloidosis - Vimarsana News

ACC Issues Expert Consensus Decision Pathway on Cardiac Amyloidosis

The American College of Cardiology (ACC) has published its “2023 ACC Expert Consensus Decision Pathway on Comprehensive Multidisciplinary Care for the Patient with Cardiac Amyloidosis” in the Journal of the American College of Cardiology.

New ACC Guidance on Nonstatin Therapies for LDL-C Lowering - Vimarsana News

New ACC Guidance on Nonstatin Therapies for LDL-C Lowering

The new guidance addresses the role of nonstatin therapies for lowering LDL-C, which were not addressed in the 2018 ACC/AHA guideline on management of cholesterol.

Clinical Challenges: Implementing More Guideline-Endorsed SGLT2i Use - Vimarsana News

Clinical Challenges: Implementing More Guideline-Endorsed SGLT2i Use

New strategies needed to ensure all are on board with fourth pillar of HF treatment